Outside the Box: Middlemen, not drug companies, are pushing up insulin prices, and Congress doesn’t have the right plan to fight back

Why should those who distribute insulin, such as pharmacy-benefit managers, get more than half of the money spent by consumers?

Why should those who distribute insulin, such as pharmacy-benefit managers, get more than half of the money spent by consumers?